Australia's drug approval system is under fire, with critics in the United States claiming it is too slow to approve ...

There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.

A new analysis of 340B hospital data found that the number of Disproportionate Share Hospitals (DSHs) participating in the ...

The Minister of the Interior, Mohammed-Mubarak Muntaka, has disclosed that critical security infrastructure at the Kotoka ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

Viking Therapeutics's obesity/diabetes candidates and strong financials position it for success. Read here for an investment ...

The Minister of the Interior, Mohammed-Mubarak Muntaka, has disclosed that the Narcotics Control Commission (NACOC) is currently relying on sniffer dogs at the Kotoka International Airport and other ...

Employers are also exploring administrative changes. About 29% changed plan carriers, while 16% conducted eligibility or claims audits. A notable development is the rise in pharmacy carve-outs – 32% ...

Donald Trump has 'sparked alarm' by threatening a 50% tariff on non-US copper and a 200% tariff on imported pharmaceuticals.

Patient-reported outcomes could have a prognostic and predictive impact on care for multiple myeloma.A retrospective analysis ...

American entrepreneur and investor Mark Cuban tells us why he and his partners launched the Mark Cuban Cost Plus Drug Company (MCCPDC), a public-benefit corporation and online pharmacy that ...